HCV Treatment
AASLD Hepatitis C Treatment Guidelines Updated to Include Boceprevir and Telaprevir
- Details
- Category: HCV Treatment
- Published on Monday, 17 October 2011 00:00
- Written by Liz Highleyman
The American Association for the Study of Liver Diseases (AASLD) has updated its guidelines for the treatment of genotype 1 chronic hepatitis C virus (HCV) infection, reflecting the advent of new direct-acting antiviral agents (DAAs).
The latest guidelines, published in the October 2011 issue of Hepatology (available free online), are also endorsed by the Infectious Diseases Society of America (IDSA), the American College of Gastroenterology, and the National Viral Hepatitis Roundtable.
EACS 2011: People on Methadone Maintenance Can Be Successfully Treated for Hepatitis C
- Details
- Category: HCV Treatment
- Published on Thursday, 13 October 2011 00:00
- Written by Liz Highleyman
Opiate users on methadone maintenance therapy can be successfully treated for chronic hepatitis C virus (HCV) infection and can achieve outcomes similar to those of patients not on methadone, according to data presented at the 13th European AIDS Conference (EACS 2011) this week in Belgrade.
Coffee Helps Reduce Side Effects in HIV/HCV Coinfected People during Interferon-based Therapy
- Details
- Category: HCV Treatment
- Published on Friday, 07 October 2011 00:00
- Written by Liz Highleyman
HIV/HCV coinfected people who drink at least 3 cups of coffee daily were less likely to experienced adverse events related to interferon-based therapy for hepatitis C, according to a French study presented at the 10th AIDS Impact Conference last month in Santa Fe. However, whether coffee somehow directly relieves side effects remains unknown.
FDA Approves Pegasys Autoinjector for Hepatitis C Patients
- Details
- Category: HCV Treatment
- Published on Tuesday, 11 October 2011 00:00
- Written by FDA
The U.S. Food and Drug Administration (FDA) recently approved an autoinjector for pegyalted interferon alfa-2a, which will make it more convenient for hepatitis C patients to self-administer the medication.
Adherence to Interferon-Based Therapy for Hepatitis C Slips Over Time
- Details
- Category: HCV Treatment
- Published on Tuesday, 04 October 2011 00:00
- Written by Liz Highleyman
Adherence to interferon-based therapy for hepatitis C virus (HCV) infection tends to decrease over time, and poorer adherence leads to lower likelihood of sustained virological response, researchers reported in the September 20, 2011, Annals of Internal Medicine.
More Articles...
- Telaprevir (Incivo) for Chronic Hepatitis C Approved in Europe
- Pharmasset Starts Trial of PSI-7977 and PSI-938 Oral Regimens for All HCV Genotypes
- ICAAC 2011: BMS-790052 plus Standard Therapy Cures Most Genotype 1 Hepatitis C Patients
- Telaprevir plus Standard Therapy Can Produce Hepatitis C Cure in Less Time
Web Design and Development by